US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Purdue Pharma L.P.

Track this case

Case overview

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

  1. September 23, 2024

    Purdue Gets 35 More Days To Mediate New Ch. 11 Deal

    Bankrupt OxyContin maker Purdue Pharma LP on Monday won its latest extension to mediate a new settlement with creditors, while also shielding Sackler family members who own the company from lawsuits, after its previous deal was scuttled by the U.S. Supreme Court in June.

  2. September 05, 2024

    Purdue Gets Mediation, Injunction Extension In Ch. 11

    OxyContin maker Purdue Pharma LP received bankruptcy court approval on Thursday to extend its ongoing mediation for another 18 days and to continue the litigation shield protecting the Sackler family members who own the company, as parties seek consensus on a new Chapter 11 plan structure.

  3. July 15, 2024

    Giuliani Booted, Purdue Regroups, Redbox Pivots

    Rudy Giuliani's Chapter 11 case was tossed for his lack of financial disclosures, Purdue Pharma pressed for renewed plan mediation as creditors hedged their bets by seeking permission to sue its owners, and the parent company of Redbox pivoted to a liquidation due to what it described as mismanagement of the business.

  4. July 09, 2024

    Purdue Plans 'High-Speed' Bid For New Ch. 11 Plan

    Purdue Pharma told a New York bankruptcy judge Tuesday that it plans a two-month "high-speed, high-stakes" attempt to replace the Chapter 11 plan shot down by the U.S. Supreme Court last month before unleashing litigation on its former owning family.

  5. July 08, 2024

    Purdue Creditors Look To Sue Sacklers After Justices' Ruling

    The official committee of unsecured creditors in the Chapter 11 case of drugmaker Purdue Pharma asked a New York bankruptcy judge on Monday for standing to bring actions against members of the Sackler family that own the company after the U.S. Supreme Court torpedoed a precarious settlement among the parties.

  6. April 17, 2024

    NY Court OKs Purdue Pharma's 5th KEIP For $7.2M

    A New York bankruptcy judge on Wednesday approved bankrupt drug manufacturer Purdue Pharma LP's plan to pay out $7.2 million to three executives and agreed to seal some of the specifics of how the executives' performance would be measured.

  7. September 21, 2023

    Canadian Tribe Denied More Time To Appeal Purdue Injunction

    A New York bankruptcy judge Thursday denied a Canadian First Nation's request to extend its deadline to appeal an injunction blocking it from moving forward with a state court opioid suit against bankrupt drugmaker Purdue Pharma LP.

  8. August 23, 2023

    Canadian Tribe's Lawsuit 'Perplexing,' Purdue Tells NY Court

    Purdue Pharma LP has asked a New York bankruptcy judge to reject a Canadian First Nation's attempt to move opioid claims forward against the drugmaker and its Sackler family owners, saying the tribe failed to meet a notice of appeal deadline to challenge the newest of many injunctions.

  9. June 16, 2023

    Purdue Seeks Ch. 11 Stay Extension To Implement Its Plan

    Bankrupt drugmaker Purdue Pharma LP told a New York judge Friday that it does not anticipate any opposition to its motion to extend the Chapter 11 stay of litigation against nondebtor third parties that has been in place for several years, saying the termination of the stay would harm the implementation of its plan.

  10. May 23, 2023

    Purdue Approved For OTC Biz Sale As Ch. 11 Case Drags On

    A New York bankruptcy judge approved a $397 million sale of Purdue Pharma's over-the-counter drug business Tuesday, but unsecured creditors say they are concerned about the potential delay in having the proceeds from the transaction distributed by the debtor.